MedTrace Logo

Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients

NCT07089589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6898

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this multicenter observational study is to determine whether preoperative statin use reduces major adverse cardiovascular events or other complications after liver transplantation. The main question it aims to answer is:

Does preoperative statin use reduce major adverse cardiovascular events or other complications after liver transplantation? The records of participants who already took statins before liver transplantation will be reviewed.

Conditions

Interventions

DRUG

Preoperative Statin Use

Administration of any statin medication prior to liver transplantation. Statin therapy was previously prescribed by the treating physician before the transplant procedure, not assigned by the study protocol.

Sponsors & Collaborators

  • Samsung Medical Center

    collaborator OTHER

  • Inje University Haeundae Paik Hospital

    collaborator OTHER

  • Asan Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-02
Primary Completion
2026-01-25
Completion
2026-03-22

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07089589 on ClinicalTrials.gov